http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MY-119697-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65583
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-59
filingDate 1999-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62a0fa984b3ff70976d59b2fec95d396
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fc0c74b635f2592ce500afa1565993d
publicationDate 2005-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MY-119697-A
titleOfInvention Process for preparing tricyclic compounds having antihistaminic activity
abstract DISCLOSED IS A PROCESS FOR PREPARING A COMPOUND HAVING THE FORMULA:WHEREIN R1 IS SELECTED FROM THE GROUP CONSISTING OF: ALKYL, ALKENYL, ALKYNYL, ARYL, ARALKYL, CYCLOALKYL, AND CYLOALKYLALKYL, R1 BEING OPTIONALLY SUBSTITUTED BY SUBSTITUENTS SELECTED FROM HALO, -OH, ALKYL, ALKOXY, OR-CF3, SAID PROCESS COMPRISING THE FOLLOWING STEPS:(A) REACTING A KETONE HAVING THE FORMULAWITH A CARBANION HAVING THE FORMULAWHEREIN R1 IS AS DEFINED ABOVE, AND R2 AND R3 ARE INDEPENDENTLY SELECTED FROM THE GROUP CONSISTING OF -OR(A) AND -R(A), WHEREIN R(A) IS ALKYL, PHENYL, SUBTITUTED PHENYL, CYCLOALKYL, SUBSTITUTED CYLOALKYL, CYCLOALKYLALKYL, OR SUBSTITUTED CYCLOALKYLALKYL;(B) TREATING THE REACTION MIXTURE FROM STEP (A) WITH A PROTONATING AGENT TO FORM A ß-HYDROXY INTERMEDIATE HAVING THE FORMULA WHEREIN R1, R2 AND R3 ARE AS DEFINED ABOVE; AND(C) THERMALLY DECOMPOSING THE ß-HYDROXY INTERMEDIATE TO FORM THE COMPOUND OF FORMULA (I). THE COMPOUNDS MADE BY THIS PROCESS HAVE ANTIHISTAMIC ACTIVITY, E.G., LORATADINE. ALSO DISCLOSED IS A PROCESS FOR PREPARING DESCARBOETHOXYLORATADINE, BY CARRYING OUT THE PROCESS ABOVE, AND CONVERTING THE PRODUCT TO DESCARBOETHOXYLORATADINE. ALSO DISCLOSED ARE NOVEL INTERMEDIATES HAVING THE FORMULAWHEREIN R1, R2 AND R3 ARE AS DEFINED ABOVE.
priorityDate 1998-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4282233-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4282233-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554006
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506932
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124087
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3957

Total number of triples: 24.